This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of the child

Authoring team

Seek expert guidance.

The management of status epilepticus in the child entails:

  • an airway should be maintained and oxygen given.
  • place in semi-prone position and protect against self- injury or over zealous restraint.
  • test for hypoglycaemia and treat if present. Take blood for U + E 's, Ca, Mg and glucose.

With regards to drug management, a systematic review has been undertaken:

  • (1) Intravenous lorazepam is at least as effective as and safer than intravenous diazepam in children
    • associated with fewer adverse events in the treatment of acute tonic-clonic convulsions
  • (2) Buccal midazolam is more effective than rectal diazepam in children in the emergency management of convulsive seizures
    • evidence supports the use of buccal midazolam as the first line treatment of acute tonic-clonic seizures in childhood including convulsive status epilepticus where intra-venous access in unavailable
  • (3) Intranasal lorazepam is more effective (less likely to require additional drugs to terminate seizure), safer and cheaper than intramuscular paraldehyde in the treatment of acute tonic clonic seizures

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.